BTO_0001948
stringlengths 11
11
| JURKAT E-6.1 cell
stringlengths 2
47
| Human, blood, leukemia, T cell line, clone E6.1.
stringlengths 20
1.28k
|
---|---|---|
EFO_0022576 | EC-9706 | Human esophageal carcinoma cell line |
EFO_0022577 | D-270MG | Human glioblastoma cell line |
EFO_0022578 | G-292 | Human osteosarcoma cell line |
EFO_0022580 | BL-41 | Human Burkitt lymphoma cell line; established from the tumor tissue of an 8-year-old Caucasian boy with Burkitt lymphoma |
EFO_0022583 | SNU-251 | Human ovarian endometrial cancer cell line |
EFO_0022584 | SACC-LM | Human salivary gland adenoid cystic carcinoma cell line |
EFO_0022586 | M249 | Human melanoma cell line BRAF V600E mutation |
EFO_0022587 | HKB-11 | Human somatic cell hybridoma (fused human embryonic kidney cells (293S) and modified Burkitt's lymphoma cells (2B8)) |
EFO_0022588 | EUFA143 | Human Fanconi anemia cell line |
EFO_0022589 | EUFA121 | Human Fanconi anemia cell line |
EFO_0022592 | CAL-33 | Human tongue squamous cell carcinoma established from the surgically removed fragment of a tongue lesion from a 69-year-old man with moderately differentiated squamous cell carcinoma of the tongue in 1983 (prior to therapy). |
EFO_0022593 | YTS-Eco | Human NK cell lymphoblastic leukemia/lymphoma cell line |
EFO_0022594 | HCN-1A | Human cortical neuronal cell line, established from a 18 months old female patient that suffered from unilateral megalencephaly. |
EFO_0022595 | PNT2 | Human normal prostate epithelium cell line immortalized with SV40. |
EFO_0022616 | BD-215 | Human Fanconi anemia cell line |
EFO_0022617 | MM200 | Human melanoma cell line |
EFO_0022618 | MGR3 | Human glioblastoma cell line |
EFO_0022619 | Rh-28 | Human alveolar rhabdomyosarcoma cell line |
EFO_0022620 | CFBE41o- | Human Cystic fibrotic bronchial epithelial cell line |
EFO_0022621 | OECM-1 | Human oral squamous cell carcinoma cell line |
EFO_0022622 | LCL 721.221 | Human lymphoblastoid cell line |
EFO_0022623 | SOSP-9607 | Human osteosarcoma cell line |
EFO_0022625 | ST-1 | Human adult T cell lymphoma cell line |
EFO_0022626 | C666 | Human nasopharyngeal carcinoma cell line |
EFO_0022627 | U-178MG | Human astrocytoma cell line |
EFO_0022629 | TPC-1 | Human papillary thyroid carcinoma cell line |
EFO_0022630 | AC16 | Human hybrid cardiomyocyte |
EFO_0022632 | 2BS | Human transformed human fetal lung cell line |
EFO_0022633 | IHCF | Human immortalized corneal fibroblast |
EFO_0022634 | H157 | Human oral squamous cell carcinoma cell line |
EFO_0022635 | PRIESS | EBV-transformed human lymphoblastoid cell line |
EFO_0022636 | FET | Human colorectal cancer cell line |
EFO_0022637 | T47D:A18 | Human invasive breast carcinoma |
EFO_0022638 | SK-UT-2 | Human endometrial carcinoma cell line |
EFO_0022639 | MO3.13 | Human hybrid cell line that express phenotypic characteristics of primary oligodendrocytes |
EFO_0022640 | SAVC | Human B-lymphoblastoid cell line |
EFO_0022641 | BM9 | Human B-lymphoblastoid cell line |
EFO_0022642 | PLH | Human B-lymphoblastoid cell line |
EFO_0022643 | BON-1 | Human pancreatic neuroendocrine tumor cell line |
EFO_0022644 | PH5CH8 | Human hepatocyte cell line |
EFO_0022645 | CWR-R1 | Human prostate carcinoma cell line |
EFO_0022646 | HER911 | Human embryonic retinoblasts |
EFO_0022647 | C-28/I2 | Immortalized human chondrocyte cell line |
EFO_0022648 | 253J-BV | Highly metastatic variant from human transitional cell carcinoma |
EFO_0022649 | KHYG-1 | Human natural killer cell leukemia |
EFO_0022650 | UPCI-SCC-131 | Human oral squamous cell carcinoma cell line |
EFO_0022651 | IHKE-1 | Human immortalized kidney epithelial cell line |
EFO_0022652 | C3ABR | Human lymphoblastoid cell line |
EFO_0022653 | Hs-578Bst | Human breast epithelial cell line |
EFO_0022654 | MLS 2645-94 | Human myxoid liposarcoma cell line |
EFO_0022655 | MLS 402-91 | Human myxoid liposarcoma cell line |
EFO_0022657 | HOM-2 | Human B-lymphoblastoid cell line |
EFO_0022658 | TE-1 | Human esophageal squamous cell carcinoma cell line |
EFO_0022659 | EoL-1 | Human eosinophilic leukaemia cell line |
EFO_0022660 | PITOUT | Human lymphoblastoid cell line |
EFO_0022661 | LCL1 | Human lymphoblastoid cell line |
EFO_0022662 | OSU-2 | Human fibroblast cell line |
EFO_0022663 | HuH-7-Lunet | Human hepatocellular carcinoma cell line |
EFO_0022664 | Colo-320 | Human colorectal cancer cell line |
EFO_0022665 | SF-188 | Human glioma cell line |
EFO_0022667 | RCB2099 | immortal human esophagus-derived cell line |
EFO_0022668 | OVCAR-10 | Human ovarian carcinoma cell line |
EFO_0022669 | 8505C | Human cell line derived from thyroid cancer. Poorly differentiated papillary adenocarcinoma |
EFO_0022670 | UWR1 | Human anaplastic astrocytoma cell line |
EFO_0022671 | UWR2 | Human glioblastoma cell line |
EFO_0022672 | GES-1 | Human normal gastric epithelial cell line |
EFO_0022673 | BHP5-16 | Human amelanotic melanoma cell line |
EFO_0022674 | K1 | Human thyroid gland papillary carcinoma cell line |
EFO_0022675 | NCI-H3122 | immortal human lung-derived cell line |
EFO_0022676 | SW-1736 | Human anaplastic thyroid cancer cell line |
EFO_0022677 | 5-8F | High tumorigenic and metastatic subline of SUNE-1 cell line |
EFO_0022678 | HCCLM-3 | Human hepatocellular carcinoma cell line |
EFO_0022679 | SACC-83 | Human salivary gland adenoid cystic carcinoma |
EFO_0022680 | T2 | Human-human somatic cell hybrid cell line, established by PEG-mediated fusion of the B-lymphoblastoid cell line LCL 721.174 with an 8-azaguanine and ouabain-resistant variant of the T-LCL CEM. Subclone of the T1 cell line which has lost both CEM(R)-derived copies of chromosome 6 |
EFO_0022681 | SO-Rb50 | Human retinoblastoma cell line |
EFO_0022682 | Flp-In-T-REx | T-REx cell derivative with targeted integration of a Flp-In expression vector |
EFO_0022683 | T-REx-HeLa | Human papillomavirus-related cervical adenocarcinoma |
EFO_0022684 | T/C-28a2 | Human chondrocyte cell line |
EFO_0022685 | PER.C6 | transformed human retinoblast cell line |
EFO_0022686 | HEK293S GnTI- | N-glycosylation by a tetracycline-inducible N-acetylglucosaminyltransferase I-negative HEK293S stable mammalian cell line |
EFO_0022687 | HuTu-80 | Human duodenal adenocarcinoma cell line |
EFO_0022688 | LAN-5 | Human neuroblastoma cell line |
EFO_0022689 | FU-OV-1 | Human ovarian serous adenocarcinoma cell line |
EFO_0022690 | 697 | Human acute lymphoblastic leukemia cell line |
EFO_0022691 | BPH-1 | Human benign prostate hyperplasia; prostate epithelial cells from a 68-year-old man with benign prostate hyperplasia; cells were immortalized with SV-40 large T-antigen; cells were described to express cytokeratins 8, 18, and 19 (but not 14) and to metabolize prostatic androgens |
EFO_0022692 | IMR-5 | Human neuroblastoma cell line |
EFO_0022693 | HET-1A | Human esophageal cell line; derived in 1986 from human esophageal autopsy tissue by transfection with plasmid pRSV-T consisting of the RSV-LTR promoter and the sequence encoding the simian virus 40 large T-antigen |
EFO_0022694 | MOLM-13 | Human acute myeloid leukemia cell line; established from the peripheral blood of a 20-year-old man with acute myeloid leukemia AML FAB M5a at relapse in 1995 after initial myelodysplastic syndromes |
EFO_0022695 | U6A | The 2fTGH-U6A Cell Line is part of a panel of IFNy pathway mutant fibrosarcoma cell lines isolated by chemical mutagenesis of IFNy insensitive reporter cells derived from HT1080 cells. |
EFO_0022696 | HVTs-SM1 | Immortalized human vascular smooth muscle cells |
EFO_0022697 | tsA-201 | A transformed human kidney 293 cell line stably expressing an SV40 temperature-sensitive T antigen |
EFO_0022698 | XPCS2BA | XPCS2BA; also has features of Cockayne syndrome; no evidence of malignancy; bilateral sensorineural hearing loss; dry skin; numerous freckles; hyperpigmented macules; broad-based choreoathetotic gait; brother of GM13025; donor subject is homozygous for a T>C transversion in the ERCC3 gene which results in a phenylalanine-99-to-serine missense mutation [PHE99SER (F99S)]. |
EFO_0022699 | RAO-3 | RAO-3 was established by transduction of the Q61L mutant RAS into human mammary epithelial cells that were immortalized with catalytic subunit of telomerase (hTERT) |
EFO_0022700 | EW-7 | Human Ewing Sarcoma cell line |
EFO_0022701 | MCF-7/C4-12 | Human invasive breast carcinoma |
EFO_0022702 | OV-2008 | Human cystadenocarcinoma cell line |
EFO_0022703 | HSC-3 | Human oral squamous cell carcinoma cell line |
EFO_0022704 | NCM-460 | Nonmalignant human colonic epithelial cell line |
EFO_0022705 | U3118MG | Human glioblastoma cell line |
EFO_0022706 | U3082MG | Human glioblastoma cell line |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.